AMRN -23%/AH on November adcomm (and PDUFA 3-month delay to late Dec): https://finance.yahoo.com/news/amarin-announces-fda-notification-advisory-203000547.html I’m not sure why investors apparently thought an adcomm wouldn’t happen; my opinion has always been that it would (#msg-144877121).